DEBORAH SEYMOUR: Open Payments
NPI 1275175739 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 90 payments from 8 companies in 2025. Trend: 2023 $985 · 2024 $1,501 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $580 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $305 |
| Novo Nordisk Inc | 3 | $59 |
| Corium, LLC | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 1 | $38 |
| Alkermes, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, UBRELVY, QULIPTA, Azstarys, SPRAVATO, Ozempic, Wegovy.
Industry payments across CT — which companies pay providers there.
